Homeβ€ΊSearchβ€ΊLeukemia

Leukemia

Springer Nature Β· United Kingdom

ISSN0887-6924eISSN1476-5551
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
149
days submission β†’ published
measured Β· last 19 articles Β· accept 121d
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
3.675
H-Indexi
256
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
2.466
Total Worksi
11,622
Total Citationsi
622,868
2yr Mean Citednessi
5.63
Open Impact Factor alternative
Retractions
9
Source: Retraction Watch

Aims & Scope

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. We publish a range of content types including original research articles, reviews, letters, correspondence and comments that elaborate on significant advances in the field and cover topical issues.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Publishedβ€”
FrequencyMonthly
StatusActive
Total Publications11,622
Publisher OrgSpringer Nature
Visit Journal Website

Submission Info

Publishing ModelHybrid
Peer Reviewpeer reviewed
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
⚑ Hybrid journal β€” subscription model available.

Think.Check.Submit Compliance

8/12 Β· 67%
βœ…
Do you know the journal / publisher?
Springer Nature
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
0887-6924 / 1476-5551
βœ…
Indexed in a trusted database?
WoS, Scopus
βœ…
Peer review process documented?
peer reviewed
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
360
19k
2019
416
21k
2020
373
14k
2021
329
16k
2022
316
5.3k
2023
370
4k
2024
341
1.5k
2025
184
66
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Anesthesiology and Pain MedicineQ1
Cancer ResearchQ1
HematologyQ1
OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyCancer ResearchAnesthesiology and Pain MedicineOncology

Research Topics (OpenAlex)

Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and Treatment

Frequently asked questions about Leukemia

Is Leukemia a predatory journal?

PubScope has no integrity flags on record for Leukemia: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Leukemia?

Leukemia is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 5.63.

Is Leukemia indexed in Scopus and Web of Science?

Leukemia is indexed in Web of Science, Scopus.

What is the aims and scope of Leukemia?

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. We publish a range of content types including original research articles, reviews, letters, correspondence and comments that elaborate on significant advances in the field and cover topical issues.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref